Compounds of formula (I) are disclosed which are vitronectin receptor antagonists useful in the treatment of osteoporosis.
1
式(I)的化合物被披露,它们是在治疗骨质疏松症中有用的维特龙蛋白受体拮抗剂。
VITRONECTIN RECEPTOR ANTAGONISTS
申请人:SMITHKLINE BEECHAM CORPORATION
公开号:EP0895475A1
公开(公告)日:1999-02-10
EP0895475A4
申请人:——
公开号:EP0895475A4
公开(公告)日:2000-08-23
[EN] VITRONECTIN RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DU RECEPTEUR DE VITRONECTINE
申请人:SMITHKLINE BEECHAM CORPORATION
公开号:WO1997024122A1
公开(公告)日:1997-07-10
(EN) Compounds of formula (I) are disclosed which are vitronectin receptor antagonists useful in the treatment of osteoporosis.(FR) Composés de la formule (I) constituant des antagonistes du récepteur de la vitronectine utiles pour le traitement de l'ostéoporose.